Inventor
JOOSS KARIN
US21 patents
⚠️ This page may combine multiple inventors who share the name “JOOSS KARIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOSANTE PHARMACEUTICALS INC
7 patentsUS7709224B2May 4, 2010
Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
BIOSANTE PHARMACEUTICALS INC19 citations91
US7662623B2Feb 16, 2010
Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
BIOSANTE PHARMACEUTICALS INC14 citations91
US7714119B2May 11, 2010
AAV vector compositions and methods for enhanced expression of immunoglobulins using the same
BIOSANTE PHARMACEUTICALS INC15 citations83
US7919079B2Apr 5, 2011
Cancer immunotherapy compositions and methods of use
BIOSANTE PHARMACEUTICALS INC16 citations82
US7632509B2Dec 15, 2009
Methods to express recombinant proteins from lentiviral vectors
BIOSANTE PHARMACEUTICALS INC7 citations69
US7939271B2May 10, 2011
Methods and compositions for identifying prostate cancer or a humoral immune response against prostate cancer
BIOSANTE PHARMACEUTICALS INC4 citations60
US7901902B2Mar 8, 2011
Methods and compositions for identifying a cellular immune response against prostate cancer
BIOSANTE PHARMACEUTICALS INC3 citations60
GRITSTONE BIO INC
6 patentsUS12109257B2Oct 8, 2024
Alphavirus neoantigen vectors
GRITSTONE BIO INC1 citations67
US11510973B2Nov 29, 2022
Alphavirus antigen vectors
GRITSTONE BIO INC1 citations67
US11771747B2Oct 3, 2023
Multiepitope vaccine cassettes
GRITSTONE BIO INC2 citations65
US12098383B2Sep 24, 2024
Modified adenoviruses
GRITSTONE BIO INC0 citations59
US11591619B2Feb 28, 2023
Modified adenoviruses
GRITSTONE BIO INC1 citations59
US11504421B2Nov 22, 2022
Alphavirus neoantigen vectors
GRITSTONE BIO INC1 citations57
CELL GENESYS INC
3 patentsUS7498024B2Mar 3, 2009
Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site
CELL GENESYS INC32 citations92
US7485291B2Feb 3, 2009
Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
CELL GENESYS INC33 citations92
US7186699B2Mar 6, 2007
Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
CELL GENESYS INC52 citations91